WE ARE NOW CONDUCTING TELEHEALTH VISITS. CONTACT THE FRONT OFFICE AT (310) 312-5050 TO SCHEDULE AN APPOINTMENT.
JONATHAN CORREN M.D. AND ASSOCIATES
Allergy, Asthma & Immunology
Phone 310-312-5050
Fax 310-575-9292
CLINICAL RESEARCH
Our Clinical Research Division
​
Dr. Corren has been involved in clinical research in the fields of allergy, asthma and immunology for over 25 years and has participated in pioneering studies of new biologic medications, unique forms of allergen immunotherapy, and new formulations of IVIG for patients with severe asthma, nasal polyps, atopic dermatitis, hives, severe nasal allergies, and immune deficiency. Please visit the following links to learn more about a few of Dr. Corren’s recent publications:
​
-
Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma.
-
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.
​
To visit our Research Division Facebook page, click here.
​
Why Participate In Clinical Research?
​
Many patients have allergic and immune disorders which are not well-controlled with existing treatments. Our practice works with the National Institute of Health and many pharmaceutical companies to help develop medications that are safer and more effective than current therapies. By participating in a clinical trial, you may help your own condition, and just as importantly, will contribute significantly to improved health and well-being for millions of patients throughout the world who suffer from asthma, severe nasal and sinus disease, allergic skin disorders, and immune deficiency.
​